Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Quillet

Showing results (11-20 of 24) with videos related to

Pageof 3
Sort By:
Journal of Immunology (Baltimore, Md. : 1950)|April 1, 1986
Interleukin 2 (IL 2) up-regulates its own receptor on a subset of human unprimed peripheral blood lymphocytes and triggers their proliferationA Harel-Bellan, J Bertoglio, A Quillet, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 1, 1988
Increased resistance to non-MHC-restricted cytotoxicity related to HLA A, B expression. Direct demonstration using beta 2-microglobulin-transfected Daudi cellsA Quillet, F Presse, C Marchiol-Fournigault, et al.
British Journal of Cancer|April 1, 1990
Recombinant gamma interferon provokes resistance of human breast cancer cells to spontaneous and IL-2 activated non-MHC restricted cytotoxicityN Jabrane-Ferrat, F Calvo, A Faille, et al.
Journal of Clinical Immunology|May 1, 1989
Effects of interferon-gamma (IFN-gamma) and tumor necrosis factor-alpha (TNF-alpha) on the expression of LFA-1 in the moderate phenotype of leukocyte adhesion deficiency (LAD)M T Dimanche-Boitrel, F Le Deist, A Quillet, et al.
International Journal of Cancer|February 1, 1991
Target lysis by human LAK cells is critically dependent upon target binding properties, but LFA-1, LFA-3 and ICAM-1 are not the major adhesion ligands on targetsA Quillet-Mary, L Cavarec, N Kermarrec, et al.
Leukemia|May 14, 2010
Immune recovery after fludarabine-cyclophosphamide-rituximab treatment in B-chronic lymphocytic leukemia: implication for maintenance immunotherapyL Ysebaert, E Gross, E Kühlein, et al.
Leukemia|October 22, 2005
TNFalpha stimulates NKG2D-mediated lytic activity of acute myeloid leukemic cellsF Guilloton, A de Thonel, C Jean, et al.
Molecular Pharmacology|January 12, 1999
Daunorubicin- and mitoxantrone-triggered phosphatidylcholine hydrolysis: implication in drug-induced ceramide generation and apoptosisA Bettaïeb, I Plo, V Mansat-De Mas, et al.
Leukemia|March 1, 1996
Daunorubicin-induced internucleosomal DNA fragmentation in acute myeloid cell linesA Quillet-Mary, V Mansat, E Duchayne, et al.
Molecular Pharmacology|October 26, 1999
Implication of radical oxygen species in ceramide generation, c-Jun N-terminal kinase activation and apoptosis induced by daunorubicinV Mansat-de Mas, C Bezombes, A Quillet-Mary, et al.
Pageof 3

Showing results (11-20 of 24) with videos related to

Sort By:
Pageof 3
Journal of Immunology (Baltimore, Md. : 1950)|April 1, 1986
Interleukin 2 (IL 2) up-regulates its own receptor on a subset of human unprimed peripheral blood lymphocytes and triggers their proliferationA Harel-Bellan, J Bertoglio, A Quillet, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 1, 1988
Increased resistance to non-MHC-restricted cytotoxicity related to HLA A, B expression. Direct demonstration using beta 2-microglobulin-transfected Daudi cellsA Quillet, F Presse, C Marchiol-Fournigault, et al.
British Journal of Cancer|April 1, 1990
Recombinant gamma interferon provokes resistance of human breast cancer cells to spontaneous and IL-2 activated non-MHC restricted cytotoxicityN Jabrane-Ferrat, F Calvo, A Faille, et al.
Journal of Clinical Immunology|May 1, 1989
Effects of interferon-gamma (IFN-gamma) and tumor necrosis factor-alpha (TNF-alpha) on the expression of LFA-1 in the moderate phenotype of leukocyte adhesion deficiency (LAD)M T Dimanche-Boitrel, F Le Deist, A Quillet, et al.
International Journal of Cancer|February 1, 1991
Target lysis by human LAK cells is critically dependent upon target binding properties, but LFA-1, LFA-3 and ICAM-1 are not the major adhesion ligands on targetsA Quillet-Mary, L Cavarec, N Kermarrec, et al.
Leukemia|May 14, 2010
Immune recovery after fludarabine-cyclophosphamide-rituximab treatment in B-chronic lymphocytic leukemia: implication for maintenance immunotherapyL Ysebaert, E Gross, E Kühlein, et al.
Leukemia|October 22, 2005
TNFalpha stimulates NKG2D-mediated lytic activity of acute myeloid leukemic cellsF Guilloton, A de Thonel, C Jean, et al.
Molecular Pharmacology|January 12, 1999
Daunorubicin- and mitoxantrone-triggered phosphatidylcholine hydrolysis: implication in drug-induced ceramide generation and apoptosisA Bettaïeb, I Plo, V Mansat-De Mas, et al.
Leukemia|March 1, 1996
Daunorubicin-induced internucleosomal DNA fragmentation in acute myeloid cell linesA Quillet-Mary, V Mansat, E Duchayne, et al.
Molecular Pharmacology|October 26, 1999
Implication of radical oxygen species in ceramide generation, c-Jun N-terminal kinase activation and apoptosis induced by daunorubicinV Mansat-de Mas, C Bezombes, A Quillet-Mary, et al.
Pageof 3